Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Interest & Investment Income (2016 - 2026)

Angiodynamics (ANGO) has disclosed Interest & Investment Income for 9 consecutive years, with -$102000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 143.59% year-over-year to -$102000.0, compared with a TTM value of $32000.0 through Nov 2025, down 98.22%, and an annual FY2025 reading of $978000.0, down 39.41% over the prior year.
  • Interest & Investment Income was -$102000.0 for Q4 2025 at Angiodynamics, down from -$4000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $606000.0 in Q3 2024 and bottomed at -$102000.0 in Q4 2025.
  • Average Interest & Investment Income over 3 years is $248600.0, with a median of $184500.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income skyrocketed 409.24% in 2024, then plummeted 143.59% in 2025.
  • Year by year, Interest & Investment Income stood at $534000.0 in 2023, then tumbled by 56.18% to $234000.0 in 2024, then crashed by 143.59% to -$102000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for ANGO at -$102000.0 in Q4 2025, -$4000.0 in Q3 2025, and $3000.0 in Q2 2025.